Advertisement
"BSGI is an emerging technology that goes beyond mammography as aneffective imaging procedure for early breast cancer detection," said Dr.Rachel Brem, Director of Breast Imaging and Intervention at George WashingtonUniversity Medical Center in Washington, D.C., and Vice Chair of theDepartment of Radiology.
Advertisement
In this study, a retrospective review was performed on the records of allpatients who had BSGI examinations over a three-year period. Among these, 159women who had only one suspicious or cancerous breast lesion on a physicalexam and/or mammography, underwent BSGI to evaluate additional cancerouslesions in the breasts, and were proven by pathology to have one or more areasof breast cancer.
BSGI detected an additional suspicious lesion, previously undetectable bymammogram and physical exam, in 46 women (29 percent). BSGI identifiedclinically and mammographically hidden cancer in 15 of 39 women who had abiopsy or prophylactic excision due to BSGI findings (36 percent) and in 15women who underwent BSGI in this study (9 percent), including nine women inwhom the hidden cancer was present in the same breast as the indicated lesion(6 percent) and six women in whom the undetectable cancer was found in theopposite breast (3 percent).
BSGI for the study was conducted using a Dilon 6800 Gamma Camera, a high-resolution, small field-of-view gamma camera, optimized to perform breastimaging. Dr. Brem and colleagues have published numerous articles on breastcancer-related topics including new technologies for the early diagnosis ofbreast cancer and BSGI.
About Dilon Technologies
Dilon Technologies Inc. is bringing innovative new medical imagingproducts to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI, amolecular breast imaging procedure which images the metabolic activity ofbreast lesions through radiotracer uptake. Many leading medical centers aroundthe country are now offering BSGI to their patients, including: CornellUniversity Medical Center, New York; George Washington University MedicalCenter, Washington, D.C.; and The Rose, Houston.
For more information on Dilon Technologies please visithttp://www.dilon.com.
SOURCE Dilon Technologies Inc.
